MCID: DSS010
MIFTS: 32

Dissociative Disorder

Categories: Mental diseases

Aliases & Classifications for Dissociative Disorder

MalaCards integrated aliases for Dissociative Disorder:

Name: Dissociative Disorder 12 14 69
Dissociative Disorders 42
Dissociative Reaction 12
Dissociative Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10935
ICD10 33 F44.9 F48.9 F44
ICD9CM 35 300.15 300.9
MeSH 42 D004213
NCIt 47 C92197
SNOMED-CT 64 154883004 44376007

Summaries for Dissociative Disorder

Disease Ontology : 12 A disease of mental health in which the normally well-integrated functions of memory, identity, perception, or consciousness are separated (dissociated).

MalaCards based summary : Dissociative Disorder, also known as dissociative disorders, is related to multiple personality disorder and dissociative amnesia. An important gene associated with Dissociative Disorder is TNFSF11 (TNF Superfamily Member 11). The drugs Ranibizumab and Triamcinolone have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and brain.

Wikipedia : 72 Dissociative disorders (DD) are conditions that involve disruptions or breakdowns of memory, awareness,... more...

Related Diseases for Dissociative Disorder

Graphical network of the top 20 diseases related to Dissociative Disorder:



Diseases related to Dissociative Disorder

Symptoms & Phenotypes for Dissociative Disorder

Drugs & Therapeutics for Dissociative Disorder

Drugs for Dissociative Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 114)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
2
Triamcinolone Approved, Vet_approved Phase 4,Phase 3 124-94-7 31307
3
Sertraline Approved Phase 4 79617-96-2 68617
4
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
5
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
6
Gemifloxacin Approved, Investigational Phase 4 175463-14-6 5464436 9571107
7
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
8
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
9
Norfloxacin Approved Phase 4 70458-96-7 4539
10
Ofloxacin Approved Phase 4 82419-36-1 4583
11
Ketamine Approved, Vet_approved Phase 4,Phase 2,Early Phase 1 6740-88-1 3821
12
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
13
Remifentanil Approved Phase 4 132875-61-7 60815
14
Rasagiline Approved Phase 4 136236-51-6 3052776
15
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
16
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
17
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
18
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
19
Verteporfin Approved, Investigational Phase 4 129497-78-5
20 Antidepressive Agents Phase 4,Phase 3,Early Phase 1
21 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Early Phase 1
22 Neurotransmitter Uptake Inhibitors Phase 4
23 Psychotropic Drugs Phase 4,Phase 2,Phase 3
24
Serotonin Phase 4 50-67-9 5202
25 Serotonin Agents Phase 4
26 Serotonin Uptake Inhibitors Phase 4
27 Angiogenesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
28 Angiogenesis Modulating Agents Phase 4,Phase 2,Phase 3,Phase 1
29 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
30 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Early Phase 1
31 Antipsychotic Agents Phase 4
32 Autonomic Agents Phase 4
33 Tranquilizing Agents Phase 4,Phase 3,Phase 2
34 triamcinolone acetonide Phase 4,Phase 3
35 Triamcinolone diacetate Phase 4,Phase 3
36 Triamcinolone hexacetonide Phase 4,Phase 3
37 Anti-Bacterial Agents Phase 4
38 Anti-Infective Agents Phase 4,Phase 1
39 beta-Lactams Phase 4
40 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
41 Cytochrome P-450 Enzyme Inhibitors Phase 4
42 Fluoroquinolones Phase 4
43 Lactams Phase 4
44 Norgestimate, ethinyl estradiol drug combination Phase 4
45 Nucleic Acid Synthesis Inhibitors Phase 4
46 Renal Agents Phase 4
47 Topoisomerase Inhibitors Phase 4
48 Analgesics Phase 4,Phase 2,Early Phase 1
49 Anesthetics Phase 4,Phase 2,Early Phase 1
50 Anesthetics, Dissociative Phase 4,Phase 2,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 110)

id Name Status NCT ID Phase Drugs
1 On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) Unknown status NCT01670162 Phase 4 Aflibercept
2 Treatment Trial for Psychogenic Nonepileptic Seizures Completed NCT00835627 Phase 4 sertraline
3 Treatments for Psychogenic Nonepileptic Seizures (NES) Completed NCT00159965 Phase 4 sertraline;placebo
4 An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment Completed NCT01881438 Phase 4
5 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
6 Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments Completed NCT00976222 Phase 4 intravitreal injection with ranibizumab
7 Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD) Completed NCT02142296 Phase 4 Eylea
8 Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy Completed NCT01935115 Phase 4 Propofol;Ketamine
9 Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment Recruiting NCT02068625 Phase 4 Rasagiline;Placebo
10 Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic Active, not recruiting NCT02007928 Phase 4
11 Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy Withdrawn NCT01666236 Phase 4
12 Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment Unknown status NCT00404209 Phase 3
13 Comparison High-Density Silicone Oils in Retinal Detachment Unknown status NCT00403702 Phase 2, Phase 3 Oxane HD [oil-RMN3-mixture];Densiron [(F6H8)
14 Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial Unknown status NCT00370279 Phase 3
15 Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus Completed NCT00381771 Phase 2, Phase 3
16 Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments Completed NCT00590694 Phase 2, Phase 3 ranibizumab
17 Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. Recruiting NCT02834559 Phase 3 5-fluorouracil and low molecular weight heparin;Placebo
18 Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder Recruiting NCT03002077 Phase 3 Rapastinel
19 Treatment of Globus Sensations With Psychotherapy Active, not recruiting NCT01590992 Phase 2, Phase 3
20 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy Active, not recruiting NCT01976923 Phase 3 Intravitreal bevacizumab
21 Naltrexone in Borderline Personality Disorder Terminated NCT00124839 Phase 3 Naltrexone
22 Rehabilitation of Conversion Gait Disorder Unknown status NCT01422278 Phase 1, Phase 2
23 Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Unknown status NCT00831350 Phase 2 Ranibizumab
24 Lucentis to Treat Pigment Epithelial Detachment Completed NCT00841581 Phase 2 Ranibizumab
25 Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder Completed NCT01133301 Phase 2 Naltrexone;Placebo
26 Body-Oriented Therapy for Sexual Abuse Recovery Completed NCT00097305 Phase 2
27 Ranibizumab for Diabetic Traction Retinal Detachment Completed NCT01201161 Phase 2 Ranibizumab
28 Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) Completed NCT00690768 Phase 2 Bevacizumab
29 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment Completed NCT00198471 Phase 2 Vitrase
30 Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder Completed NCT02067793 Phase 2 NRX-1074 1 mg;Placebo;NRX-1074 5 mg;NRX-1074 10 mg
31 Treating PTSD in Patients With Borderline Personality Disorder Completed NCT01081314 Phase 1, Phase 2
32 Open Label Ketamine Treatment for Major Depressive Disorder in Veterans Recruiting NCT03053830 Phase 2 Ketamine
33 Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment Terminated NCT00083967 Phase 2 denufosol tetrasodium (INS37217) Intravitreal Injection
34 HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration Terminated NCT01189019 Phase 2 ranibizumab;ranibizumab
35 Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment Unknown status NCT01261533 Phase 1
36 Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment Unknown status NCT00548197 Phase 1 Bevacizumab
37 A Study in Subjects With Retinal Detachment Completed NCT00210067 Phase 1 denufosol tetrasodium (INS37217) Intravitreal Injection
38 Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments Completed NCT00749021 Phase 1 Ranibizumab;Ranibizumab;Ranibizumab;Ranibizumab
39 Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment Recruiting NCT02841306 Phase 1 Ursodeoxycholic Acid
40 Cannabinoids, Learning, and Memory Recruiting NCT02407808 Phase 1 THC;Placebo
41 Cannabinoids, Neural Synchrony, and Information Processing Active, not recruiting NCT00708994 Phase 1 THC;Placebo
42 Psychotherapy and Pharmacotherapy in Dissociative Disorders Unknown status NCT00630981 Pharmacological treatment (Quetiapine and/or Escitalopram)
43 Psychopathology of Dissociative Disorders Unknown status NCT01388140
44 Exploration and Characterization of Genetic and Phenotypic Profile of the"Schizotiste" Unknown status NCT02565524
45 Cognitive Behavioural Therapy in Dissociative Seizures Unknown status NCT00688727
46 Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye Unknown status NCT02201706
47 DOREFA (Retinal Detachment: Function and Anatomy) Unknown status NCT01767038
48 Corneal Endothelial Cell Loss After Pneumatic Retinopexy for the Repair of Primary Rhegmatogenous Retinal Detachment Unknown status NCT02185469 sulfur hexafluoride (SF6)
49 Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration Unknown status NCT01521819 Lucentis
50 Prevalence of Dissociative Disorders in Children Completed NCT01512641

Search NIH Clinical Center for Dissociative Disorder

Cochrane evidence based reviews: dissociative disorders

Genetic Tests for Dissociative Disorder

Anatomical Context for Dissociative Disorder

MalaCards organs/tissues related to Dissociative Disorder:

39
Eye, Endothelial, Brain, Testes, Retina, Cortex, Prefrontal Cortex

Publications for Dissociative Disorder

Articles related to Dissociative Disorder:

(show top 50) (show all 69)
id Title Authors Year
1
Predicting a dissociative disorder from type of childhood maltreatment and abuser-abused relational tie. ( 28318411 )
2017
2
Relationship of cognitive function and adjustment difficulties among children and adolescents with dissociative disorder. ( 27114655 )
2016
3
Unique and Overlapping Symptoms in Schizophrenia Spectrum and Dissociative Disorders in Relation to Models of Psychopathology: A Systematic Review. ( 27209638 )
2016
4
Assessment of complex dissociative disorder patients and simulated dissociation in forensic contexts. ( 28029435 )
2016
5
Childhood Traumatic Experiences, Dissociative Symptoms, and Dissociative Disorder Comorbidity Among Patients With Panic Disorder: A Preliminary Study. ( 26011585 )
2015
6
Dissociative disorder manifesting for underlying adolescent hemi-parkinsonism: New chronology for old mummies. ( 26189361 )
2015
7
Child Abuse and Neglect in Complex Dissociative Disorder, Abuse-Related Chronic PTSD and Mixed Psychiatric Samples. ( 26275087 )
2015
8
Dissociative, Depressive, and PTSD Severity as Correlates of Non-Suicidal Self-Injury and Suicidality in Dissociative Disorder Patients. ( 26211678 )
2015
9
Hyperglycemia associated dissociative fugue (organic dissociative disorder) in an elderly. ( 26286620 )
2015
10
Dissociative amnesia in dissociative disorders and borderline personality disorder: self-rating assessment in a college population. ( 24678926 )
2014
11
Dissociative disorder due to Graves' hyperthyroidism: a case report. ( 24713328 )
2014
12
Childhood maltreatment and intimate partner violence in dissociative disorder patients. ( 25279109 )
2014
13
An outpatient clinical study of dissociative disorder not otherwise specified. ( 24461163 )
2014
14
Dissociation, shame, complex PTSD, child maltreatment and intimate relationship self-concept in dissociative disorder, chronic PTSD and mixed psychiatric groups. ( 25451418 )
2014
15
Personality assessment inventory profile and predictors of elevations among dissociative disorder patients. ( 24060036 )
2013
16
Dissociative disorder induced by clarithromycin combined with rabeprazole in a patient with gastritis. ( 23569151 )
2013
17
Folie A deux mixed dissociative disorder--a case report. ( 24309892 )
2013
18
Jactatio corporis nocturna and dissociative disorder: a case report. ( 22648876 )
2012
19
Intracranial capillary hemangioma mimicking a dissociative disorder. ( 24765434 )
2012
20
Dissociative symptoms and dissociative disorder comorbidity in patients with obsessive-compulsive disorder. ( 22425531 )
2012
21
An exploration of young adults' progress in treatment for dissociative disorder. ( 22989245 )
2012
22
Teaching Chinese psychiatrists to make reliable dissociative disorder diagnoses. ( 21911511 )
2011
23
Topiramate-induced Dissociative Disorder. ( 21922065 )
2011
24
A case of obsessive-compulsive disorder presenting as dissociative disorder: the role of sodium thiopental interview. ( 21977374 )
2011
25
New-onset dissociative disorder after electroconvulsive therapy. ( 19935087 )
2010
26
Sociodemographic profile of normal EEG-dissociative disorder (convulsion) patients. ( 20112839 )
2009
27
Dissociative disorder and dissociation - comparison with healthy controls. ( 20038932 )
2009
28
Type of presentation of dissociative disorder and frequency of co-morbid depressive disorder. ( 19208316 )
2009
29
Sleep-related dissociative disorder in a 6-year-old girl. ( 18629686 )
2008
30
Long-term outcome and prognosis of dissociative disorder with onset in childhood or adolescence. ( 18651951 )
2008
31
Sociodemographic features, affective symptoms and family functioning in hospitalized patients with dissociative disorder (convulsion type). ( 17319415 )
2007
32
The older female patient with a complex chronic dissociative disorder. ( 17588883 )
2007
33
Restoring literary wholeness to the fragmented account of Antoine Despine's magnetic cure of Estelle L'Hardy's dissociative disorder. ( 17786663 )
2007
34
Acute disseminated encephalomyelitis initially diagnosed as dissociative disorder. ( 17827422 )
2007
35
Should conversion disorder be reclassified as a dissociative disorder in DSM V? ( 17878494 )
2007
36
Neural correlates of enhanced working-memory performance in dissociative disorder: a functional MRI study. ( 17018171 )
2007
37
Axis I dissociative disorder comorbidity in borderline personality disorder and reports of childhood trauma. ( 17107251 )
2006
38
Dissociative disorder during pregnancy. ( 17130040 )
2006
39
Why conversion seizures should be classified as a dissociative disorder. ( 16530593 )
2006
40
Attention-deficit/hyperactivity disorder and dissociative disorder among abused children. ( 16884444 )
2006
41
Cognitive function and dissociative disorder status among veteran subjects with chronic posttraumatic stress disorder: a preliminary study. ( 16720800 )
2006
42
Dissociative disorder underdiagnosed due to undescriptive criteria? ( 16946198 )
2006
43
Dissociative disorder presenting as catatonia. ( 21408047 )
2004
44
Dissociative disorder in children. A case study. ( 15457142 )
2004
45
Serum lipid levels in patients with dissociative disorder. ( 15514416 )
2004
46
Intravenous diazepam for dissociative disorder: memory lost and found. ( 12832603 )
2003
47
Dissociative disorders in Turkish inpatients with conversion disorder. ( 12923711 )
2003
48
Re: Canadian and American psychiatrists' attitudes toward dissociative disorder diagnoses. ( 11987482 )
2002
49
Dissociative disorder associated with a colloid cyst of the third ventricle: organic or psychogenic amnesia? ( 10671832 )
2000
50
The evolving standard of care in the practice of trauma and dissociative disorder therapy. ( 10842448 )
2000

Variations for Dissociative Disorder

Expression for Dissociative Disorder

Search GEO for disease gene expression data for Dissociative Disorder.

Pathways for Dissociative Disorder

GO Terms for Dissociative Disorder

Sources for Dissociative Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....